Intervention

N-Acetylcysteine

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials13

Recruiting3

Common conditions20

Lead sponsors shown13

Clinical trials

13 shown

Efficacy & Safety of Dry Powder Ivy Extract (Syrup Prospan) Versus NAC Among COPD PatientsNCT06377410 · 2024-05-01

RECRUITING

Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione LevelsNCT05241262 · 2023-07-06

RECRUITING

Effects of NAC on Symptoms of CHR PatientsNCT05142735 · 2023-01-13

RECRUITING

A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-AcetylcysteineNCT06546475 · 2024-08-01

NOT_YET_RECRUITING

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.NCT03510741 · 2019-01-01

COMPLETED

Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?NCT03104725 · 2017-09-25

TERMINATED

"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"NCT03149107 · 2016-09-01

TERMINATED

Effect of N-acetylcysteine on Brain GlutamateNCT02483130 · 2015-06-01

COMPLETED

N-Acetylcysteine for Patients With COPD and Chronic BronchitisNCT01739790 · 2013-01-01

TERMINATED

A Clinical Trial for CTD-ILD TreatmentNCT01424033 · 2011-12-01

TERMINATED

Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on InflammationNCT01550432 · 2011-06-01

COMPLETED

A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in SchizophreniaNCT01232790 · 2010-02-01

COMPLETED

N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing ChemotherapyNCT00637624 · 2008-03-01

TERMINATED

Common conditions

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

chronic obstructive pulmonary disease2 psychotic disorder2 schizophrenia2 chronic bronchitis1 connective tissue disorder1 hyperlipidemia1 interstitial lung disease1 mesothelioma1 mitochondrial disease1 non-small cell lung carcinoma1 obesity disorder1 Parkinson disease1 schizoaffective disorder1 small cell lung carcinoma1

Leading sponsors

Centre for Addiction and Mental Health 1 King's College London 1 Michio Hirano, MD 1 National Institute of Neurological Disorders and Stroke (NINDS) 1 National Taiwan University Hospital 1 National University of Malaysia 1 Pakistan Institute of Living and Learning 1 Rijnstate Hospital 1 Stanford University 1 University Hospital, Bonn 1 University of Michigan 1 University of Minnesota 1 Yale University 1

Trial status mix

TERMINATED5

COMPLETED4

RECRUITING3

NOT_YET_RECRUITING1

Phase mix

NA6

PHASE12

PHASE22

PHASE32

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.